Expression profiles of the Glucose-dependent insulinotropic peptide receptor and LHCGR in sporadic adrenocortical tumors

Journal of Endocrinology

Volumn 200, Issue 2, 2009, Pages 167-175

  Costa, Marcia Helena Soares ^a   Latronico, Ana Claudia ^a   Martin, Regina Matsunaga ^a   Barbosa, Angela S ^a   Almeida, Madson Q ^a   Lotfi, Claudimara Ferini Pacicco ^a   Lima Valassi, Helena P ^a   Nishi, Miriam Yumie ^a   Lucon, Antonio Marmo ^a   Siqueira, Sheila Aparecida ^a   Zerbini, Maria Cladia Nogueira ^a   Carvalho, Luciani Renata ^a   Mendonca, Berenice Bilharinho ^a   Fragoso, Maria Candida Barisson Villares ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; MESSENGER RNA;

ADOLESCENT; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 67449159213     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0395     Document Type: Article

References (51)

1. Abdallah MA, Lei ZM, Li X, Greenwold N, Nakajima ST, Jauniaux E & Rao ChV 2004 Human fetal nongonadal tissues contain human chorionic gonadotropin/luteinizing hormone receptors. Journal of Clinical Endocrinology and Metabolism 89 952-956.
2. Almeida MQ & Latronico AC 2007 The molecular pathogenesis of childhood adrenocortical tumors. Hormone and Metabolic Research 39 461-466.
3. Almeida MQ, Fragoso MC, Lotfi CF, Santos MG, Nishi MY, Costa MH, Lerario AM, Maciel CC, Mattos GE, Jorge AA et al. 2008 Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 93 3524-3531.
4. Antonini SR, N'Diaye N, Hamet P, Tremblay J & Lacroix A 2002 Analysis of the putative promoter region of the GIP receptor gene (GIPR) in GIP-dependent Cushing's syndrome (CS). Endocrine Research 28 755-756.
5. Antonini SR, N'Diaye N, Baldacchino V, Hamet P, Tremblay J & Lacroix A 2004 Analysis of the putative regulatory region of the gastric inhibitory polypeptide receptor gene in food-dependent Cushing's syndrome. Journal of Steroid Biochemistry and Molecular Biology 91 171-177.
6. Antonini SR, Baldacchino V, Tremblay J, Hamet P & Lacroix A 2006 Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome. Clinical Endocrinology 64 29-36.
7. Ascoli M, Fanelli F & Segaloff DL 2002 The lutropin /choriogonadotropin receptor, a 2002 perspective. Endocrine Reviews 23 141-174.
8. Barbosa AS, Giacaglia LR, Martin RM, Mendonca BB & Lin CJ 2004 Assessment of the role of transcript for GATA-4 as a marker of unfavorable outcome in human adrenocortical neoplasms. BMC Endocrine Disorders 4 1-11.
9. Bourdeau I, Antonini SR, Lacroix A, Kirschner LS, Matyakhina L, Lorang D, Libutti SK & Stratakis CA 2004 Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene 23 1575-1585.
10. Bourdeau I, Lampron A, Costa MH, Tadjine M & Lacroix A 2007 Adrenocorticotropic hormone-independent Cushing's syndrome. Current Opinion in Endocrinology, Diabetes and Obesity 14 219-225.
11. Chabre O, Liakos P, Vivier J, Chaffanjon P, Labat-Moleur F, Martinie M, Bottari SP, Bachelot I, Chambaz EM, Defaye G et al. 1998 Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis. Journal of Clinical Endocrinology and Metabolism 83 3134-3143.
12. Else T, Giordano TJ & Hammer GD 2008 Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma. Journal of Clinical Endocrinology and Metabolism 93 1442-1449.
13. Feelders RA, Lamberts SW, Hofland LJ, van Koetsveld PM, Verhoef-Post M, Themmen AP, de Jong FH, Bonjer HJ, Clark AJ, van der Lely AJ et al. 2003 Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. Journal of Clinical Endocrinology and Metabolism 88 230-237.
14. Fragoso MC, Domenice S, Latronico AC, Martin RM, Pereira MA, Zerbini MC, Lucon AM & Mendonca BB 2003 Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. Journal of Clinical Endocrinology and Metabolism 88 2147-2151.
15. Goodarzi MO, Dawson DW, Li X, Lei Z, Shintaku P, Rao CV & Van Herle AJ 2003 Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone. Journal of Clinical Endocrinology and Metabolism 88 73-77.
16. Groussin L, Perlemoine K, Contesse V, Lefebvre H, Tabarin A, Thieblot P, Schlienger JL, Luton JP, Bertagna X & Bertherat J 2002 The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors. Journal of Clinical Endocrinology and Metabolism 87 1980-1985.
17. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS & Stratakis CA 2000 Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nature Genetics 26 89-92.
18. Koch CA, Pacak K & Chrousos GP 2002 The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. Journal of Clinical Endocrinology and Metabolism 87 5367-5384.
19. Kroeze WK, Sheffler DJ & Roth BL 2003 G-protein-coupled receptors at a glance. Journal of Cell Science 116 4867-4869.
20. Lacroix A, Bolte E, Tremblay J, Dupre J, Poitras P, Fournier H, Garon J, Garrel D, Bayard F, Taillefer R et al. 1992 Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. New England Journal of Medicine 327 974-980.
21. Lacroix A, Hamet P & Boutin JM 1999a Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. New England Journal of Medicine 341 1577-1581.
22. Lacroix A, Mirescu H & Hammet P 1999b Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome. Endocrinologist 9 9-15.
23. Lacroix A, N'Diaye N, Tremblay J & Hamet P 2001 Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocrine Reviews 22 75-110.
24. Lacroix A, Baldacchino V, Bourdeau I, Hamet P & Tremblay J 2004 Cushing's syndrome variants secondary to aberrant hormone receptors. Trends in Endocrinology and Metabolism 15 375-382.
25. Lampron A, Bourdeau I, Hamet P, Tremblay J & Lacroix A 2006 Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 91 3611-3618.
26. Latronico AC, Pinto EM, Domenice S, Fragoso MC, Martin RM, Zerbini MC, Lucon AM & Mendonca BB 2001 An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 86 4970-4973.
27. Lebrethon MC, Avallet O, Reznik Y, Archambeaud F, Combes J, Usdin TB, Narboni G, Mahoudeau J & Saez JM 1998 Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients. Journal of Clinical Endocrinology and Metabolism 83 4514-4519.
28. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 402-408.
29. Luton JP, Bertherat J, Kuhn JM & Bertagna X 1998 Aberrant expression of the GIP (gastric inhibitory polypeptide) receptor in an adrenal cortical adenoma responsible for a case of food-dependent Cushing's syndrome. Bulletin de l'Acadèmie Nationale de Mèdecine 182 1839-1849 (discussion 1849-1850).
30. Macfarlane DA 1958 Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases. Annals of the Royal College of Surgeons of England 23 155-186.
31. Mazzuco TL, Chabre O, Feige JJ & Thomas M 2006a Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. Journal of Clinical Endocrinology and Metabolism 91 196-203.
32. Mazzuco TL, Chabre O, Sturm N, Feige JJ & Thomas M 2006b Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Endocrinology 147 782-790.
33. McFarland KC, Sprengel R, Phillips HS, Kohler M, Rosemblit N, Nikolics K, Segaloff DL & Seeburg PH 1989 Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 245 494-499.
34. Mendonca BB, Lucon AM, Meekness CA, Saldanha LB, Latronico AC, Zerbini C, Madureira G, Domenice S, Albergaria MA, Camargo MH et al. 1995 Clinical, hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood. Journal of Urology 154 2004-2009.
35. Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P & Lacroix A 2000 Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? Journal of Clinical Endocrinology and Metabolism 85 3531-3536.
36. N'Diaye N, Tremblay J, Hamet P, De Herder WW & Lacroix A 1998 Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 83 2781-2785.
37. N'Diaye N, Hamet P, Tremblay J, Boutin JM, Gaboury L & Lacroix A 1999 Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 84 2616-2622.
38. Noordam C, Hermus AR, Pesman G, N'Diaye N, Sweep CG, Lacroix A & Otten BJ 2002 An adolescent with food-dependent Cushing's syndrome secondary to ectopic expression of GIP receptor in unilateral adrenal adenoma. Journal of Pediatric Endocrinology and Metabolism 15 853-860.
39. Pinto EM, Billerbeck AE, Villares MC, Domenice S, Mendonca BB & Latronico AC 2004 Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors. Arquivos Brasileiros de Endocrinologia e Metabologia 48 647-650.
40. Pinto EM, Billerbeck AE, Fragoso MC, Mendonca BB & Latronico AC 2005 Deletion mapping of chromosome 17 in benign and malignant adrenocortical tumors associated with the Arg337His mutation of the p53 tumor suppressor protein. Journal of Clinical Endocrinology and Metabolism 90 2976-2981.
41. Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, Lebrethon MC, Budi I, Balliere AM & Mahoudeau J 1992 Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. New England Journal of Medicine 327 981-986.
42. Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G et al. 2001 An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. PNAS 98 9330-9335.
43. Sandrini R, Ribeiro RC & DeLacerda L 1997 Childhood adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 82 2027-2031.
44. Saner-Amigh K, Mayhew BA, Mantero F, Schiavi F, White PC, Rao CV & Rainey WE 2006 Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. Journal of Clinical Endocrinology and Metabolism 91 1136-1142.
45. Sullivan M, Boileau M & Hodges CV 1978 Adrenal cortical carcinoma. Journal of Urology 120 660-665.
46. Swords FM, Aylwin S, Perry L, Arola J, Grossman AB, Monson JP & Clark AJ 2005 The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease? Journal of Clinical Endocrinology and Metabolism 90 3009-3016.
47. Tsagarakis S, Tsigos C, Vassiliou V, Tsiotra P, Pratsinis H, Kletsas D, Trivizas P, Nikou A, Mavromatis T, Sotsiou F et al. 2001 Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism 86 583-589.
48. Usdin TB, Mezey E, Button DC, Brownstein MJ & Bonner TI 1993 Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133 2861-2870.
49. West AN, Neale GA, Pounds S, Figueredo BC, Rodriguez Galindo C, Pianovski MA, Oliveira Filho AG, Malkin D, Lalli E, Ribeiro R et al. 2007 Gene expression profiling of childhood adrenocortical tumors. Cancer Research 67 600-608.
50. Wieneke JA, Thompson LD & Heffess CS 2003 Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. American Journal of Surgical Pathology 27 867-881.
51. Wilkin F, Gagne N, Paquette J, Oligny LL & Deal C 2000 Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression. Journal of Clinical Endocrinology and Metabolism 85 2048-2056.